![]() Blueprint Medicines Blueprint Medicines is a biopharmaceutical company engaged in developing therapies for allergy, inflammation, and oncology/hematology. | |||
Founding Date | Founding Date 1984 | Founding Date 2011 | Founding Date 1978 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Hyderabad, IN HQ Melbourne, AU São Paulo, BR Mississauga, CA Kunshan, CN Bogotá, CO Rueil Malmaison, FR see more | Locations Cambridge, US HQ Amsterdam, NL Lugano, CH Zug, CH | Locations Madison, US HQ Alexandria, AU Sao Paulo, BR Beijing, CN Lyon, FR Walldorf, DE New Delhi, IN see more |
Employees | Employees 27,0486% increase | Employees 6552% increase | Employees 1,947 |
Financial | |||
Revenue (est.) | Revenue (est.) ₹335.9b (FY, 2026) | Revenue (est.) $508.8m (FY, 2024) | Revenue (est.) $693m (Y, 2024) |
Cost of goods | Cost of goods ₹133.1b (FY, 2026) | Cost of goods $20.2m (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit ₹207.1b (FY, 2026) | Gross profit $488.7m (FY, 2024) | Gross profit N/A |
Net income | Net income ₹41.6b (FY, 2026) | Net income ($67.1m) (FY, 2024) | Net income N/A |

Blueprint Medicines is a biopharmaceutical company engaged in developing therapies for allergy, inflammation, and oncology/hematology.
View company
Promega is a company that provides life sciences solutions.
View company